Condition: Healthy Volunteer · Sponsor: Institut Pasteur de Lille
The goal of this clinical trial is to observe a decrease in plasma LDL cholesterol concentration of 10% (or 0.20g/L) in subjects with untreated moderate hypercholesterolemia after 3 months of consumption of the Limicol®-NG food supplement, compared with a historical placebo group
This description comes directly from the study's public registry record.
Coralie Berthier, PhD · 3 20 87 73 33 · coralie.berthier@pasteur-lille.fr
Frédéric Batteux, MD · 3.20.87.73.16 · frederic.batteux@pasteur-lille.fr
Always discuss trial participation with your own doctor first.
| NutrInvest - Institut Pasteur de Lille | Lille, Nord, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06894251